Brenda Finucane

4.6k total citations
65 papers, 2.6k citations indexed

About

Brenda Finucane is a scholar working on Genetics, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, Brenda Finucane has authored 65 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Genetics, 23 papers in Molecular Biology and 23 papers in Cognitive Neuroscience. Recurrent topics in Brenda Finucane's work include Genetics and Neurodevelopmental Disorders (30 papers), Genomic variations and chromosomal abnormalities (28 papers) and Autism Spectrum Disorder Research (23 papers). Brenda Finucane is often cited by papers focused on Genetics and Neurodevelopmental Disorders (30 papers), Genomic variations and chromosomal abnormalities (28 papers) and Autism Spectrum Disorder Research (23 papers). Brenda Finucane collaborates with scholars based in United States, Canada and Belgium. Brenda Finucane's co-authors include Elisabeth M. Dykens, Robert M. Hodapp, Sarah H. Elsea, Rebecca E. Slager, Christopher N. Vlangos, Elizabeth Berry‐Kravis, Randi J. Hagerman, Liane Abrams, Flora Tassone and Elliott W. Simon and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and Nature Communications.

In The Last Decade

Brenda Finucane

60 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brenda Finucane United States 26 1.8k 1.2k 921 225 206 65 2.6k
Jeannie Visootsak United States 26 2.0k 1.1× 1.2k 1.1× 1.1k 1.2× 212 0.9× 172 0.8× 54 2.7k
Ann C. M. Smith United States 32 2.1k 1.2× 1.8k 1.6× 423 0.5× 161 0.7× 222 1.1× 95 3.9k
Petter Strømme Norway 28 1.1k 0.6× 1.2k 1.0× 311 0.3× 157 0.7× 296 1.4× 76 2.7k
Edmund C. Jenkins United States 31 1.7k 0.9× 1.1k 1.0× 822 0.9× 81 0.4× 104 0.5× 123 2.9k
Tiziano Pramparo United States 27 1.2k 0.7× 1.7k 1.5× 503 0.5× 51 0.2× 173 0.8× 50 2.7k
Bronwyn Kerr United Kingdom 32 1.3k 0.7× 1.6k 1.4× 436 0.5× 49 0.2× 153 0.7× 67 3.2k
Karen Brøndum‐Nielsen Denmark 34 2.0k 1.1× 2.3k 2.0× 514 0.6× 99 0.4× 134 0.7× 137 4.1k
Peter Huppke Germany 26 2.0k 1.1× 1.2k 1.0× 1.3k 1.4× 443 2.0× 152 0.7× 52 2.8k
W. Ted Brown United States 31 2.5k 1.4× 1.5k 1.3× 1.6k 1.7× 130 0.6× 262 1.3× 97 3.4k
Judith H. Miles United States 26 1.2k 0.6× 702 0.6× 1.4k 1.5× 290 1.3× 60 0.3× 68 2.6k

Countries citing papers authored by Brenda Finucane

Since Specialization
Citations

This map shows the geographic impact of Brenda Finucane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brenda Finucane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brenda Finucane more than expected).

Fields of papers citing papers by Brenda Finucane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brenda Finucane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brenda Finucane. The network helps show where Brenda Finucane may publish in the future.

Co-authorship network of co-authors of Brenda Finucane

This figure shows the co-authorship network connecting the top 25 collaborators of Brenda Finucane. A scholar is included among the top collaborators of Brenda Finucane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brenda Finucane. Brenda Finucane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oetjens, Matthew T., Alexander S. F. Berry, Andrés Moreno-De-Luca, et al.. (2025). Monogenic disorders associated with motor speech phenotypes in children and adolescents undergoing clinical exome sequencing. Genetics in Medicine. 27(4). 101374–101374. 2 indexed citations
2.
Walsh, Louisa, Cora Taylor, Brenda Finucane, et al.. (2024). Association of behavioural and social–communicative profiles in children with 16p11.2 copy number variants: a multi‐site study. Journal of Intellectual Disability Research. 68(8). 969–984. 1 indexed citations
3.
Berry, Alexander S. F., Brenda Finucane, Scott M. Myers, et al.. (2024). A genome-first study of sex chromosome aneuploidies provides evidence of Y chromosome dosage effects on autism risk. Nature Communications. 15(1). 8897–8897. 6 indexed citations
4.
White, Lauren K., T. Blaine Crowley, Brenda Finucane, et al.. (2023). Gathering the Stakeholder’s Perspective: Experiences and Opportunities in Rare Genetic Disease Research. Genes. 14(1). 169–169. 2 indexed citations
5.
Hu, Yirui, Scott M. Myers, Brenda Finucane, et al.. (2023). Diagnostic Yield of Exome Sequencing in Cerebral Palsy and Implications for Genetic Testing Guidelines: A Systematic Review and Meta-analysis. Obstetrical & Gynecological Survey. 78(11). 638–639. 3 indexed citations
6.
Taylor, Cora, Brenda Finucane, Andrés Moreno-De-Luca, et al.. (2022). Phenotypic shift in copy number variants: Evidence in 16p11.2 duplication syndrome. Genetics in Medicine. 25(1). 151–154. 6 indexed citations
7.
Finucane, Brenda, David H. Ledbetter, & Jacob Vorstman. (2021). Diagnostic genetic testing for neurodevelopmental psychiatric disorders: closing the gap between recommendation and clinical implementation. Current Opinion in Genetics & Development. 68. 1–8. 28 indexed citations
8.
Finucane, Brenda, Scott M. Myers, Christa Lese Martin, & David H. Ledbetter. (2020). Long overdue: including adults with brain disorders in precision health initiatives. Current Opinion in Genetics & Development. 65. 47–52. 15 indexed citations
9.
Huang, Eunice Y., Nora Urraca, Brenda Finucane, et al.. (2017). Multisite Semiautomated Clinical Data Repository for Duplication 15q Syndrome: Study Protocol and Early Uses. JMIR Research Protocols. 6(10). e194–e194. 5 indexed citations
10.
Finucane, Brenda, et al.. (2016). Prognostic dilemmas and genetic counseling for prenatally detected fragile X gene expansions. Prenatal Diagnosis. 37(1). 37–42. 2 indexed citations
11.
Finucane, Brenda, Barbara Haas‐Givler, & Elliott W. Simon. (2013). Knowledge and Perceptions About Fragile X Syndrome: Implications for Diagnosis, Intervention, and Research. Intellectual and developmental disabilities. 51(4). 226–236.
12.
Abrams, Liane, Amy Cronister, W. Ted Brown, et al.. (2012). Newborn, Carrier, and Early Childhood Screening Recommendations for Fragile X. PEDIATRICS. 130(6). 1126–1135. 29 indexed citations
13.
Finucane, Brenda, Liane Abrams, Amy Cronister, et al.. (2012). Genetic Counseling and Testing for FMR1 Gene Mutations: Practice Guidelines of the National Society of Genetic Counselors. Journal of Genetic Counseling. 21(6). 752–760. 56 indexed citations
14.
15.
Bourgeois, James A., Sarah M. Coffey, Susan M. Rivera, et al.. (2009). A Review of Fragile X Premutation Disorders. The Journal of Clinical Psychiatry. 70(6). e1–e11. 137 indexed citations
16.
Finucane, Brenda & Barbara Haas‐Givler. (2009). Smith-Magenis Syndrome: Genetic Basis and Clinical Implications. Journal of Mental Health Research in Intellectual Disabilities. 2(2). 134–148. 13 indexed citations
17.
McConkie‐Rosell, Allyn, Liane Abrams, Brenda Finucane, et al.. (2007). Recommendations from Multi‐disciplinary Focus Groups on Cascade Testing and Genetic Counseling for Fragile X‐associated Disorders. Journal of Genetic Counseling. 16(5). 593–606. 48 indexed citations
18.
Berry‐Kravis, Elizabeth, Liane Abrams, Sarah M. Coffey, et al.. (2007). Fragile X‐associated tremor/ataxia syndrome: Clinical features, genetics, and testing guidelines. Movement Disorders. 22(14). 2018–2030. 233 indexed citations
19.
Finucane, Brenda, et al.. (1999). Fragile X mutation screening among unselected pregnant women seen for genetic counseling: Findings of a pilot study. Genetics in Medicine. 1(2). 54–54. 1 indexed citations
20.
Elsea, Sarah H., Smita M. Purandare, Ramesh C. Juyal, et al.. (1997). Definition of the critical interval for Smith-Magenis syndrome. Cytogenetic and Genome Research. 79(3-4). 276–281. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026